Anti-Thrombotic Strategy After Trans-Aortic Valve Implantation for Aortic Stenosis

NCT02664649 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1510

Enrollment

OTHER

Sponsor class

Conditions

Symptomatic Aortic Stenosis
Eligible for Transcatheter Aortic Valve Replacement

Interventions

DRUG: Apixaban
DRUG: Standard of care

Sponsor

Assistance Publique - Hôpitaux de Paris

Collaborators

[object Object]
[object Object]